Discovery of GLP-1–Based Drugs for the Treatment of Obesity

已完结 10 由 John 发布于 2025/9/15 15:19:03

DOI:10.1056/nejmcibr2409089
文献类型：期刊论文
补充材料：只需要正文
文献链接：https://doi.org/10.1056/nejmcibr2409089

New England Journal of Medicine (NEJM)

Abstract：The 2024 Lasker–DeBakey Clinical Medical Research Award recognizes Drs. Habener, Mojsov, and Knudsen, who developed GLP-1 medicines that have revolutionized the treatment of obesity.

应助信息

求助已完结，文件已删除 如有需求请重新发布求助一键发布

感谢使用Book学术
本站所有文献仅供个人学习和参考，请勿将文件进行传播。共同遵守网站规定和相关知识产权规定。

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:American Association for the Advancement of Science (AAAS)Dosing interval is a major factor determining the quality of T cells induced by SARS-CoV-2 mRNA and adenoviral vector vaccines